Zhangzhou Pientzehuang Pharmaceutical (600436) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

600436 Zhangzhou Pientzehuang Pharmaceutical

Watchlist

201.39
-2.07-1.02%

Not Open Mar 4 15:00 CST

121.50BMarket Cap39.46P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
cls.cnMar 2 21:09 ET
Does Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Deserve A Spot On Your Watchlist?
Simply Wall StFeb 2 20:20 ET
The price of natural bezoar has risen under pressure, and Zhangzhou Pientzehuang Pharmaceutical's profit growth rate has returned to that of ten years ago.
The "Medicine Mace" Zhangzhou Pientzehuang Pharmaceutical (600436.SH) is entering a "slowdown" period. On January 24th, Zhangzhou Pientzehuang Pharmaceutical released the 2024 performance brief...
wallstreetcnJan 24 01:56 ET
The rise in raw material costs has led to a slowdown in the net profit growth of Zhangzhou Pientzehuang Pharmaceutical in 2024.
Encountering a Waterloo.
Gelonghui FinanceJan 23 22:04 ET
Announcement of Zhangzhou Pianziying Pharmaceutical Co., Ltd. on the 2024 Annual Results Report
SZSIJan 23 11:00 ET · Announcements
Express News | Zhangzhou Pientzehuang Pharmaceutical Prelim 2024 Net Profit up 6.3% Y/Y
ReutersJan 23 04:01 ET

Comments

Bull X Bear

Oct 4, 2024 07:12

What would you buy for your China portfolio?

Semiconductor: $Semiconductor Manufacturing International Corporation (688981.SH)$ $NAURA Technology Group (002371.SZ)$
Securities: $CITIC (600030.SH)$ $East Money Information (300059.SZ)$
Insurance: $China Life Insurance (601628.SH)$ $Ping An Insurance (601318.SH)$
Auto Parts: $Fuyao Glass Industry Group (600660.SH)$ $Weichai Power (000338.SZ)$ $Ningbo Tuopu Group (601689.SH)$
Cars: $BYD Company Limited (002594.SZ)$
Software: $Beijing Kingsoft Office Software, Inc (688111.SH)$ $Hithink RoyalFlush Information Network (300033.SZ)$ $Iflytek Co.,ltd. (002230.SZ)$
...

Officials say the real estate market is bottoming out. What’s your view on China's property market?

Moomoo AI

Feb 29, 2024 17:37

Despite a recent drop, Zhangzhou Pientzehuang Pharmaceutical's long-term returns remain impressive. The market sentiment remains steady, reflecting the EPS growth. The current sell-off could be an opportunity if sustainable growth continues.

Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Shareholders Have Earned a 17% CAGR Over the Last Five Years

Moomoo AI

Feb 11, 2024 20:10

Zhangzhou Pientzehuang Pharmaceutical's performance is commendable, with efficient reinvestment of its earnings leading to impressive earnings growth. The company's earnings growth is expected to continue at a similar rate, according to analyst forecasts.

Is Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Latest Stock Performance A Reflection Of Its Financial Health?

Moomoo AI

Dec 18, 2023 23:32

Zhangzhou Pientzehuang Pharmaceutical investors remain upbeat despite high P/E ratio. However, comfort is wavering due to the difficulty of justifying these prices long-term without substantial growth rate improvements.

Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Shares May Have Run Too Fast Too Soon

Moomoo AI

Nov 15, 2023 20:55

Zhangzhou Pientzehuang Pharmaceutical's share price reflects steady EPS growth indicating investor sentiment continuity. It appears that shareholders are rewarded generously via dividends, as suggested by total shareholder returns exceeding share price return.